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Infection with hepatitis B virus (HBV) was detected by serological testing for HBV surface antigen and by
PCR assay for HBV DNA in serum samples from two common chimpanzees (Pan troglodytes subsp. verus) born
in West Africa. The complete genome sequences obtained by nucleotide sequencing of overlapping DNA
fragments amplified by PCR were compared with HBV variants recovered from other primates and with human
genotypes A to F. Both chimpanzee sequences were 3,182 nucleotides in length, and the surface gene sequence
predicted the existence of a, d, and w serological determinants. Neither sequence contained stop codons in the
precore region. On phylogenetic analysis, the HBV variants infecting the chimpanzees clustered together with
a third chimpanzee HBV isolate independently obtained from an infected captive animal (A. J. Zuckerman, A.
Thornton, C. R. Howard, K. N. Tsiquaye, D. M. Jones, and M. R. Brambell, Lancet ii:652–654, 1978), with an
overall sequence similarity of >94%. This provides strong evidence for a chimpanzee-specific genotype of HBV
which circulates in nature. These findings add to the recent evidence for infection in the wild of other Old and
New World primates (gibbon, orangutan, and woolly monkey) with species-specific variants of HBV. There is
no evidence for close phylogenetic clustering of variants found so far in primates with any of the established
HBV genotypes from humans. With the new evidence for the widespread distribution of HBV in primates,
hypotheses for the origins of human infection are reviewed.
Hepatitis B virus (HBV) chronically infects approximately
5% of the human population. The toll of approximately one
million deaths from chronic liver disease and hepatocellular
carcinoma attributable to HBV infection per year (14) indi-
cates the extent of the global health problem posed by this
virus. HBV is transmitted by sexual contact and by parenteral
exposure, although it is thought that mother-to-child perinatal
transmission and the establishment of a lifelong highly infec-
tious carrier state are responsible for the observed high rates of
endemicity in high-prevalence regions such as South and East
Asia and sub-Saharan Africa and among indigenous peoples in
Central and South America.
HBV is classified in the family Hepadnaviridae and contains
a partly double-stranded DNA genome of approximately 3,200
bases. HBV replicates via an RNA intermediate antigenome
sequence, encoding a potentially error-prone polymerase en-
zyme with both reverse transcriptase and DNA polymerase
activities. HBV variants from different geographical regions
show genetic heterogeneity and are currently classified into six
genotypes differing from each other by nucleotide sequence
distances of approximately 10 to 13%. While genotypes A and
D have global distributions, genotypes B and C are found
predominantly in East and Southeast Asia, genotype E is found
in West Africa, and genotype F is found among indigenous
peoples in Central and South America (1, 11). Apart from
humans, a range of much more genetically divergent hepadna-
viruses infect the New World rodents woodchucks (Marmota
monax), ground squirrels (Spermophilus beecheyi), and arctic
ground squirrels (S. parryii) and a range of bird species (ducks,
geese, and grey herons).
The origins of HBV infection in humans that have led to its
current worldwide distribution have remained controversial. It
is unclear whether nonhuman primates can be infected with
HBV in the wild, as studies to date have used samples from
captive animals exposed to both human and potentially other
primate sources of infection (9, 12, 15, 17). In this study, we
have genetically characterized HBV variants infecting chim-
panzees (Pan troglodytes subsp. verus) born in the wild in West
Africa and demonstrated that they share a genotype with that
of a captive chimpanzee previously considered to have been
infected from human sources (15). The existence of a chim-
panzee-specific genotype, combined with the evidence of in-
fection in other primate species, contributes to our under-
standing of the origins of HBV infection in humans, although
a hypothesis consistent with all of the current experimental
observations remains elusive.
MATERIALS AND METHODS
Samples. Four samples from chimpanzees positive for HBV surface antigen
(HBsAg) were available for the study. Three HBsAg-positive samples were
collected from wild-born chimpanzees (Chimps 1 to 3) orphaned as a conse-
quence of the bush meat trade and housed at a rescue center in Cameroon.
Importation of samples from the center to the United Kingdom followed CITES
regulations. Chimp 4 originated from West Africa, was smuggled to Spain for use
in the beach chimp trade, confiscated by the Spanish authorities, and subse-
quently rehomed in an ape rescue center in the United Kingdom.
Chimp 2 was HBsAg positive 2 years after arrival at the center in Cameroon
but was HBsAg negative on retesting 2 years later. It has shown no signs of
clinical hepatitis during its stay at the center. Chimp 4 has been HBsAg positive
(Public Health Laboratory Service, Colindale, United Kingdom) since initial
testing after arrival in the United Kingdom and remains so 7 years later.
Amplification and nucleotide sequencing. Each HBsAg-positive sample was
assayed by PCR for HBV DNA sequences. Nucleic acid was extracted from
200-ml volumes of serum by the Nuclisens extractor (Organon-Teknika, Boxtel,
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The Netherlands). Three microliters of extracted DNA was then amplified in a
PCR mixture containing Access reagents (Promega, Chilworth, Southampton,
United Kingdom) using primers S1 (59-CATCAGGAYTCCTAGGACCCCT-39;
positions 171 to 192 numbered from the EcoRI site in the HBVADW sequence;
GenBank accession no. V00866) and S5 (GAGGCATAGCAGCAGGATGMA
GAGG; positions 406 to 430; all primers were produced by Oswel DNA,
Southampton, United Kingdom). PCR conditions for all first-round amplifica-
tion steps were 1 cycle of 94°C for 2 min; 30 cycles of 94°C for 30 s, 55°C for 21 s,
and 72°C for 1.5 min; and 1 cycle of 72°C for 6 min. Amplified sequences in 1 ml
of PCR product were amplified further in a second-round PCR using internal
(nested) primers S3 (59-CGTGTTACAGGCGGKGTKTTTCTTGT-39; posi-
tions 196 to 221) and S6 (ATGATAAAACGCCGCAGACACATC; positions
379 to 402) and reagents described previously (7). The following combinations of
outer and inner nested primers were used to amplify the rest of the HBV genome
in overlapping fragments: 21 (GACTTCTCTCARTTTTCYAGGGG; positions
265 to 287) and 24 (AGTAAAYTGAGCCARGAGAAACGG; positions 661 to
684), followed by 22 and 23 (ACGGRCTRAGGCCCACTCCCATAG; positions
641 to 664); 13 (CAAYCCNYTGGGATTCTTYCCC; positions 2892 to 2913)
and 16 (CCCCTRGAAAAYTGAGAGAAGTC; positions 265 to 287), followed
by 14 (AATCCMGATTGGGACTTCAAYMC; positions 2953 to 2975) and 19
(CKGAACTGGAGCCACCARCAG; positions 69 to 89); 13 and 16, followed by
15 (GTCCACCACGAGTCTAGAYTCTK; positions 245 to 267) and 18
(CATCCTCAGGCCATGMAGTGG; positions 3181 to 3201); 21 and 24, fol-
lowed by 17 (GTCYTGGCCAAAATTCGCAGTCC; positions 300 to 322) and
23; 22 (GATGTRTCTGCGGCGTTTTATCAT; positions 379 to 402) and 12
(AGACAMAAGAAAATTGGTAAYAG; positions 800 to 822), followed by 11
and 12; 2 (ACTGTTCAAGCCTCCAAGCT; positions 1862 to 1881) and 1
(GATAGGGGCATTTGGTGGTC; positions 2301 to 2320), followed by 3 and
4; 11 (AAWTGCACWTGTATTCCCATCCC; positions 592 to 615) and 27
(CCARCCAGTGGGDGTTGCRTC; positions 1192 to 1112), followed by 25
(TGGTATTGGGGGCCAARTCTG; positions 752 to 772) and 26 (AGCAAA
CACTTGGCACAGVCC; positions 1171 to 1191); 28 (TCGCCAACTTAYA
AGGCCTTT; positions 1102 to 1122) and 31 (GCAGAGGTGAAGCGAAGT
GCA; positions 1583 to 1603), followed by 29 (CCTTTACCCCGTTGCYCG
GCA; positions 1153 to 73) and 30 (CACGGWCCGGCAGATGAGAAG; po-
sitions 1583 to 1603); 32 (ACGGGGCGCACCTCTCTTTA; positions 1522 to
1541) and 3 (AGTGCGAATCCACACTC; positions 2271 to 2287), followed by
33 (CGCGGWCTCCCCGTCTGTGC; positions 1542 to 1561) and 34 (CAAT
GYTCNGGAGACTCTAA; positions 2027 to 2046); 4 (GAGCTWCTGTGG
AGTTACTCTC; positions 1932 to 1953) and 40 (GTTTGGAARTAATGAT
TAAC; positions 2726 to 2746), followed by 35 (ACCATACNGCACTCAG
GCAAG; positions 2055 to 2075) and 39 (CTGGATAATAAGGTTTAAT;
positions 2700 to 2718); and 41 (CGTCGCMGAAGATCCAATCT; positions
2423 to 2443) and 19, followed by 42 (GTATYCCTTGGACTCATAAGG; po-
sitions 2461 to 2481) and 43 (CCACTGCATGGCCTGAGGATG; positions
3181 to 3201). Amplified DNA was directly sequenced using a commercially
available cycle sequencing method (Amersham, Amersham, United Kingdom).
Sequence analysis. Nucleotide sequences were edited and assembled using the
SIMMONIC sequence analysis package. Each amplicon was sequenced in both
directions, and most of the nucleotide sequence data was derived from two
independent readings. The two complete chimpanzee-derived HBV sequences
were aligned with a data set of 145 complete HBV genome sequences available
from GenBank (a list is available from the authors), which excluded sequences
containing insertions/deletions, and sequences shown previously to be intergeno-
type recombinants (HBVDNA [accession no. X68292] and HPBADW1 [acces-
sion no. D00329]; reference 4). For phylogenetic analysis, genotype C was re-
duced to 34 representative sequences, as they were heavily overrepresented in
the original data set, leaving 90 complete hepadnavirus genomes with an align-
ment length of 3,244 bases. The sequence of woolly monkey HBV (WMHBV)
(9) was used as an outgroup to root the phylogenetic tree. In a second phyloge-
netic analysis, the S open reading frame (ORF) sequences were extracted from
a sample of 22 hepadnaviruses (see below) and combined with those of seven
recently published S ORF sequences obtained from wild-caught orangutans
(GenBank accession no. Y17559 to Y17565; reference 16) to produce a data set
of 29 sequences of 1,212 bp.
Phylogenetic trees were constructed using a maximum-likelihood (ML)
method incorporating the general reversible Markov model of nucleotide sub-
stitution and a gamma distribution of rate variation among sites (assumed to
contain eight different rate categories), the latter of which has been shown to
have a major effect on HBV phylogenies (2). Parameter values were estimated
from the data during tree reconstruction and are available from the authors on
request. The Kishino-Hasegawa test (8) was used to compare, using ML, differ-
ent hypotheses of phylogenetic relationship among the human and primate
hepadnaviruses, although for ease of computation, this analysis was based on a
sample of 22 complete genome sequences, including all of those from nonhuman
primates and 3 from each human genotype, apart from genotype E, for which
only two complete genomes are available. Finally, to assess the robustness of the
phylogenetic groupings obtained, a bootstrap neighbor-joining (NJ) analysis with
1,000 replications was performed using the same model of nucleotide substitu-
tion as in the ML analysis. All of the phylogenetic analyses described in this
paper were performed using the PAUP* package (version 4; reference 13).
Nucleotide sequence accession numbers. The nucleotide sequences deter-
mined in this study have been submitted to the GenBank database and assigned
accession no. AF242585 and AF242586.
RESULTS
Nucleotide sequences of HBV variants from chimpanzees.
The four HBsAg-positive samples from Chimps 1 to 4 were
assayed for HBV DNA by nested PCR using primer pairs
S1-S5 and S3-S6. Samples from Chimps 2 and 4 were positive.
From these samples, complete genome sequences were ob-
tained by assembly of the nucleotide sequences of overlapping
fragments amplified with nested primers (see Materials and
Methods). The genome sequences obtained, from Chimps 2
and 4, were circular, and both were 3,182 nucleotides in length.
For comparison, the sequence lengths of representative mem-
bers of the six human HBV genotypes were 3,221 (A; HB
VADW2), 3,215 (B; HPBADW2), 3,215 (C; HPBCG), 3,182
(D; HBVGEN1), 3,212 (E; HHVBE4), and 3,215 (F; ADW4A)
nucleotides. The chimpanzee sequences were the same length
as the HPBVCG sequence obtained from an infected chim-
panzee in the London zoo (15) and the HBU46935 sequence
from a white-handed gibbon (12) but longer than the HBV
sequence from a captive woolly monkey (WMHBV; accession
no. AF046996; 3,179 bp; reference 9). The length and number
of ORFs encoding the core, surface, polymerase, and X genes
were identical to those of HPBVCG and some human HBV
genotypes.
Neither the Chimp 2 nor the Chimp 4 sequence contained a
precore stop codon, in contrast to the HPBVCG sequence. In
the surface gene, the presence of lysine residues at positions
122 and 160 predicted the existence of d and w serological
determinants, while isoleucine and alanine at positions 134 and
159 in the Chimp 4 sequence predicted w2. While the subtype
adw2 predicted for the Chimp 4 sequence is shared with the
HPBVCG sequence, the Chimp 2 sequence contains the less
common amino acid residues leucine and valine at positions
134 and 159, making subtype prediction more problematic.
Pairwise comparison of the chimpanzee sequences with
other HBV variants (Table 1) showed the Chimp 2 and 4
sequences to be most closely related to the HPBVCG se-
quence (2.4 to 5.8% sequence divergence) and distinct from
human genotypes (8.9 to 13.1% divergence) or the primate
sequences HBU46935 (gibbon; 9 and 9.8% divergence) and
WMHBV (22.1 and 22.2% divergence). The pairwise distance
between Chimps 2 and 4 (6% divergence) was greater than the
mean pairwise distances between members of the same human
genotype (1.2 to 4.5% divergence between representative se-
quences of genotypes A to F used for Table 1).
Phylogenetic analysis of hepadnavirus genomes. Evolution-
ary relationships among 90 representative complete hepadna-
virus genome sequences rooted by that from the woolly mon-
key (WMHBV) were analyzed by ML analysis with NJ
bootstraps (Fig. 1). Chimps 2 and 4 formed a strongly sup-
ported clade with the virus previously obtained from the Lon-
don Zoo chimpanzee (100% bootstrap support), thereby con-
stituting powerful evidence that all three animals are infected
with a chimpanzee-specific virus. The distinctive nature of the
six human genotypes was also apparent (all had 100% boot-
strap support), although, with the exception of a D-E grouping,
intergenotype relationships were uncertain in that none had
strong bootstrap support, as was the case with the placement of
the gibbon virus. It is therefore difficult to resolve the branch-
ing order of the human and primate viruses on these data,
although it is noteworthy that the chimpanzee and gibbon
4254 MACDONALD ET AL. J. VIROL.
viruses fell within, rather than outside, the human part of the
tree.
To determine the extent of phylogenetic resolution in these
data in more statistically rigorous fashion, we undertook a
series of likelihood significance tests, although, for ease of
computation, this analysis was performed on a smaller sample
of 22 representative viruses (see Materials and Methods).
First, 10 model tree topologies were constructed based on the
ML tree of all 90 sequences (Fig. 1) but with the WMHBV
sequence occupying different positions, thereby generating to-
pologies in which the chimpanzee and gibbon viruses, as well as
each human genotype, were pictured as the first to diverge.
Next, the likelihoods of these model topologies were estimated
on the data and compared using the Kishino-Hasegawa test
(Table 2). Although a tree with genotype B as the most diver-
gent had the highest likelihood, as was also the case for the ML
tree of all 90 complete genomes, the nine competing topologies
had very similar likelihoods; only the trees in which genotype D
or E diverged first were significantly worse than the best (B),
although a tree with genotypes D and E placed together as the
most divergent could not be rejected. This analysis reveals that
there is little phylogenetic resolution at the base of this tree,
perhaps because the WMHBV sequence is too divergent to
serve as a viable outgroup. Finally, ML trees for this sample of
22 viruses were also constructed on the genome regions cov-
ered by single or double reading frames taken separately and
with the most variable sites in the sequence removed. In no
case did this produce a major change in branching order (the
trees are not shown but are available from the authors on
request).
In a second phylogenetic analysis, we constructed trees on
TABLE 1. Sequence divergencea between new chimpanzee variants and other HBV variants
Source of genome
sequence Chimp 4 HPBVCG Gibbon
Human HBV genotypesb:
WMHBV
A B C D E F
Chimp 2 0.0598 0.0582 0.0900 0.0996 0.1065 0.1047 0.1032 0.0891 0.1261 0.2210
Chimp 4 0.0239 0.0976 0.0987 0.1054 0.1069 0.1064 0.0936 0.1309 0.2223
HPBVCG 0.0905 0.0956 0.1021 0.1007 0.1004 0.0900 0.1243 0.2229
Gibbon 0.1023 0.1072 0.1007 0.1109 0.1036 0.1294 0.2235
A 0.0895 0.0892 0.0970 0.0992 0.1355 0.2229
B 0.0913 0.1047 0.1095 0.1376 0.2170
C 0.1038 0.1044 0.1354 0.2168
D 0.0752 0.1345 0.2191
E 0.1330 0.2194
F 0.2325
a Uncorrected nucleotide distances measured between complete genome sequences.
b Mean pairwise distances among five representative sequences from genotypes A to D, two of genotype E, and three of genotype F.
FIG. 1. ML phylogenetic analysis of complete genome sequences of Chimps
2 and 4, other primates, and available sequences of human genotypes A to F
(genotype C is restricted to 34 representative sequences). The tree was rooted
with the outgroup WMHBV. NJ bootstrap values of $70% are indicated on
branches.
TABLE 2. Likelihoods of different tree topologies
Treea 2Ln Lb Diff 2ln L SD (diff) t Pc
A 19,113.91571 8.21828 4.75478 1.7284 0.0840
B 19,105.69743 Best
C 19,108.31650 2.61907 5.75045 0.4555 0.6488
D 19,122.28125 16.58382 8.05901 2.0578 0.0397
E 19,122.49123 16.79380 8.08440 2.0773 0.0379
D 1 E 19,118.31469 12.61726 6.57211 1.9198 0.0550
F 19,113.65749 7.96006 8.69884 0.9151 0.3602
Chimpanzees 19,113.09801 7.40058 8.78119 0.8428 0.3994
Gibbon 19,113.15832 7.46089 8.75796 0.8519 0.3943
Apesd 19,113.15832 7.46089 8.75795 0.8519 0.3943
a Most divergent clade on tree (excluding the WMHBV outgroup).
b L, likelihood of tree.
c Probability of getting a more extreme t value under the null hypothesis of no
difference between the two trees (two-tailed test). Values significant at P , 0.05
are underlined.
d Chimpanzees and gibbon.
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the S gene sequences from our sample of 22 viruses plus the 7
viruses recently obtained from orangutans by using ML anal-
ysis with NJ bootstraps (Fig. 2). Intriguingly, the orangutan
sequences were not only monophyletic, suggesting that they
were species specific, but also clustered with the virus taken
from the gibbon, an animal that occupies a similar geographic
range in Southeast Asia. There is also some (weak) support for
a phylogenetic relationship between the chimpanzee viruses
and genotypes D and E, although this is not supported at the
level of the whole genome. The remainder of the tree is similar
to that based on the 90 whole-genome sequences, apart from
the slight movement shown by the genotype A sequences.
DISCUSSION
This study provides evidence for infection of chimpanzees
(P. troglodytes subsp. verus) born in the wild. Despite the dif-
ferent geographical origins and handling histories of the two
study chimpanzees, the nucleotide sequences of HBV ampli-
fied from Chimps 2 and 4 were similar to each other but
phylogenetically distinct from those of humans or other pri-
mate species. HBV infection appeared to be relatively com-
mon among chimpanzees in West Africa; in the refuge center
in Cameroon, HBsAg screening of other wild-born chimpan-
zees has identified a further 8 positive samples among 26 tested
(J.C.M.L., unpublished data). Further PCR testing and se-
quence analysis are required to confirm the serology results
and to investigate further the distribution of the chimpanzee
genotype reported in this study.
The existence of a chimpanzee-specific genotype of HBV is
supported by the close similarity of this genotype to that of
HBV recovered from a captive chimpanzee (HPBVCG [strain
LSH]; references 15 and 17), a finding which clarifies the origin
of HBV infection in the London Zoo outbreak. The original
investigators found HBV infection in three offspring of a male
and a female that had been captured in Africa. However,
neither in the original description nor in the subsequent report
of the sequence of strain LSH were the authors able to deter-
mine whether HBV infection was acquired by either the par-
ents or the offspring in the London Zoo, by the parents after
capture in Africa (possibly by inoculation of human immuno-
globulin preparations), or in the wild from other chimpanzees.
The genetic relatedness of strain LSH to human genotypes has
led both these (15) and subsequent investigators (3, 9) to
conclude that the chimpanzee infection arose from human
contact. The discovery of the same HBV genotype in chimpan-
zees sampled independently in this study provides convincing
evidence against this hypothesis.
Whether other primate species are infected with HBV in the
wild has been controversial. Norder et al. (12) obtained the
sequence of an HBV variant (HBU46935) infecting a chim-
panzee after inoculation with serum from a captive white-
handed gibbon (Hybolates lar), although whether the original
source of HBV was from the wild has remained controversial.
However, the recent unpublished description of six complete
genome sequences of HBV that originated from gibbons (S.
Grethe et al., accession no. AJ131568 to AJ131574) and group
closely with HBU46935 (data not shown) suggests infection of
gibbons in the wild, although clarification of this hypothesis
awaits publication of the data.
HBV has also been recovered from a captive woolly monkey
(Lagothrix lagotricha; reference 9). The sequence of WMHBV
is the most divergent of all primate HBV variants, and unlike
other primate HBVs, there was some evidence for a restriction
in host range; an inoculum from an infected woolly monkey
failed to efficiently infect a chimpanzee (9). Very recently,
HBV infection was detected in a number of originally wild-
caught orangutans (16). Although sequences from the surface
gene appeared to show some relationship to the HBU46935
gibbon virus, that all seven grouped together on the tree also
implies that orangutans have a specific variant of HBV. In
summary, there is growing evidence from this and previous
studies for widespread infection of primates with HBV and for
the existence of species-specific genotypes. Furthermore, the
three genotypes recovered from Old World primate species
show a level of sequence divergence from each other (9 to
10%) similar to that among human HBV genotypes A to E.
The finding of HBV infecting native chimpanzees has a
number of implications for theories of the origins of human
HBV infection. A hypothesis for a relatively recent origin pro-
posed that HBV spread from the Americas into Europe and
elsewhere in the Old World after contact between Europeans
and indigenous peoples around 400 years ago (3). However,
the finding that chimpanzees, as well as orangutans (16), can
be infected with HBV in the wild makes the proposed recent
spread of HBV from the New World extremely unlikely.
It has been alternatively proposed that HBV infection was
present in anatomically modern humans as they migrated from
Africa approximately 150,000 to 100,000 years ago (10, 11),
FIG. 2. ML phylogenetic analysis of the HBsAg gene sequences of HBV
recovered from primates (including those from orangutans) and representative
sequences of human genotypes A to F. The tree was rooted with the WMHBV
sequence. NJ bootstrap values of $70% are indicated on branches.
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and the different genotypes infecting humans evolved since this
dispersal. The problem with the hypothesis is that it also does
not explain the origin of the various nonhuman primate viruses
which, with the exception of the variant found in woolly mon-
keys, are interspersed among the human genotypes in the phy-
logenetic tree.
Finally, it could be argued that the variants found in chim-
panzees in this study and previously in gibbons, orangutans,
and New World primate woolly monkeys are viruses that co-
evolved with their primate hosts over periods of 10 to 35
million years. The numerous genotypes found in humans
would therefore originate through multiple zoonotic transmis-
sion episodes from several nonhuman primate species infected
with different species-specific genotypes. Such a scenario is not
unprecedented; human immunodeficiency virus type 1 infec-
tion in humans originated through at least three separate
cross-species transmissions from different subspecies of chim-
panzees (6), while human infection with human immunodefi-
ciency virus type 2 in West Africa arose independently several
times through contact with sooty mangabeys (5). The first
difficulty here is that the phylogenetic tree of the various pri-
mate HBV variants in no way reflects the phylogeny of the host
species, as would be expected for cospeciation. Second, if hu-
man genotypes A to F originated in primates, then the actual
species involved in transmission to humans remain unidenti-
fied.
At this stage, the problems associated with each of three
hypotheses for the origin of HBV prevent a definitive conclu-
sion. First, as indicated previously (2), resolution of this issue
requires more extensive HBsAg screening and sequence anal-
ysis of HBV infecting wild-caught primates from each of their
three principal geographical ranges. Second, indigenous hu-
man populations in areas of high endemicity for HBV infection
(such as sub-Saharan Africa) are poorly sampled and evidence
for the existence of other genotypes should be sought. Com-
bined human and primate studies may succeed in identifying
the immediate sources of each of the six human genotypes and
the circumstances under which HBV subsequently came to be
globally distributed.
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